A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease

Description

TARGET-IBD is a 5-year, longitudinal, observational study of adult and pediatric patients (age 2 and above) being managed for Inflammatory Bowel Disease (IBD) in usual clinical practice. TARGET-IBD will create a research registry of patients with IBD within academic and community real-world practices in order to assess the safety and effectiveness of current and future therapies.

Conditions

Inflammatory Bowel Diseases, Crohn's Disease, Ulcerative Colitis, Indeterminate Colitis

Talk to us

Study Overview

On this page

Study Details

Study overview

TARGET-IBD is a 5-year, longitudinal, observational study of adult and pediatric patients (age 2 and above) being managed for Inflammatory Bowel Disease (IBD) in usual clinical practice. TARGET-IBD will create a research registry of patients with IBD within academic and community real-world practices in order to assess the safety and effectiveness of current and future therapies.

A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease

A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease

Condition
Inflammatory Bowel Diseases
Intervention / Treatment

-

Contacts and Locations

Lancaster

Om Research, Lancaster, California, United States, 93534

Mission Hills

FACEY Medical Foundation, Mission Hills, California, United States, 91345

Sacramento

University of California - Davis, Sacramento, California, United States, 95817

Stanford

Stanford University, Stanford, California, United States, 94305

Aurora

University of Colorado Denver, Aurora, Colorado, United States, 80045

Clearwater

Gastro Florida, Clearwater, Florida, United States, 33762

Jacksonville

University of Florida Health Jacksonville-Gastroenterology, Jacksonville, Florida, United States, 32207

Palm Harbor

Advanced Gastroenterology Associates, LLC, Palm Harbor, Florida, United States, 34684

Atlanta

Atlanta Gastro, Atlanta, Georgia, United States, 30342

Chicago

The University of Chicago Medical Center, Chicago, Illinois, United States, 60637

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Adults and children (age 2 or older) with a diagnosis of Crohn's disease (CD), Ulcerative colitis (UC), or Indeterminate colitis (IBDU) having been prescribed any IBD treatment (initial or subsequent) outside of a clinical trial.
  • 2. Have plans for future visits at the site for continued management of IBD.
  • 1. Inability to provide written informed consent/assent.
  • 2. Being enrolled in any interventional study or trial for IBD treatment. Note: Patient may be enrolled in other registries or studies where IBD treatment outcomes are observed and/or reported (such as center-based registries).
  • 3. Prior total abdominal colectomy for UC or IBDU.

Ages Eligible for Study

2 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Target PharmaSolutions, Inc.,

Study Record Dates

2025-07